From 31 October to 2 November, INOVOTION will be in Basel, Switzerland, at the European Antibody Congress 2017 (booth 40, MabDesign pavilion).
Our CEO Jean Viallet and Business Developer for Europe Romain Gret will present a preview of the latest progress in assessing the efficacy and toxicity of immunotherapy in oncology and answer your questions about INOVOTION’s unique in vivo platform.
As one of the pioneers developing innovative approaches in drug discovery, INOVOTION is thrilled to meet more leaders and senior executives in the field, and keep spreading the word about its fast, sensitive, reliable and affordable in vivo technology.
Set up a meeting with our CEO, the inventor of the technology jean.viallet@inovotion.com, and our Business Developer romain.gret@inovotion.com or just drop by the booth 40, at the MabDesign pavilion.
